Condition: Prostate Cancer (Post Prostatectomy) · Prostate Cancer (Adenocarcinoma) · Prostate Cancer (Diagnosis) · Sponsor: Lithuanian University of Health Sciences
This prospective observational study aims to evaluate the prognostic significance of early postoperative prostate-specific antigen (PSA) levels in patients undergoing radical prostatectomy for prostate cancer. No investigational interventions will be performed. All diagnostic procedures, follow-up assessments, and treatments will be conducted in accordance with standard clinical practice and established prostate cancer management guidelines. Participation in the study will not influence treatment decisions.
This description comes directly from the study's public registry record.
Gustas Sasnauskas, MD · +37063605330 · gustas.sas@gmail.com
Always discuss trial participation with your own doctor first.
| Lithuanian University of Health Sciences Hospital Kaunas Clinics, Department of Urology | Kaunas, Kauno, Lithuania | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07516886